title: Poxviral-based prostate-specific antigen vaccine in prostate cancer.
authors.forename: Luis
authors.initials: L
authors.lastname: León
authors.forename: María C
authors.initials: MC
authors.lastname: Areses
authors.forename: Urbano
authors.initials: U
authors.lastname: Anido
authors.forename: Antonio
authors.initials: A
authors.lastname: Gómez
authors.forename: Ana M
authors.initials: AM
authors.lastname: Carballo
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use; D019496:Cancer Vaccines / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D000077143:Docetaxel; D005822:Genetic Vectors; D006801:Humans; D008297:Male; D049451:Nomograms; D011212:Poxviridae; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000627:therapeutic use*; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000401:mortality; D016019:Survival Analysis; D043823:Taxoids / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D019496:Cancer Vaccines; D043823:Taxoids; D000077143:Docetaxel; D017430:Prostate-Specific Antigen